COH – Algo Buy Signal

Posted on | by Leon Hinde

Cochlear is now under Algo Engine buy conditions and has been added to our ASX 100 model portfolio.

We expect 10% EPS growth over the next 12 months. Although, the stock remains expensive at 40x earnings and trading on a 1.8% yield.

Since writing the above post in Dec last year, COH has rallied from $175 to a high of $257. The subsequent pullback has seen buying interest rebuild at the higher low of $210.

This is the second cluster of Algo Engine buy signals and we’ve taken the opportunity to add to our original allocation.

16/12 Update: COH remains a buy at $215.

CSL – Buy

Posted on | by Leon Hinde

CSL has lobbed a US$11.7bn all cash public tender offer for Switzerland based specialty drug company Vifor Pharma.

The acquisition is being funded via a combination of a private placement, SPP and cash/debt, with commencement around 18 Jan-22.